-
1
-
-
84908246583
-
Trial of Ebola virus vaccine is due to start next week
-
Arie S. Trial of Ebola virus vaccine is due to start next week. BMJ. 2014;349:g 5562. http://dx.doi.org/10.1136/bmj.g5562
-
(2014)
BMJ
, vol.349
, pp. 5562
-
-
Arie, S.1
-
2
-
-
2342455182
-
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses
-
Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Moller P, Wagner R, et al. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol. 2004;78:5458-65. http://dx.doi.org/10.1128/JVI.78.10.5458-5465.2004
-
(2004)
J Virol
, vol.78
, pp. 5458-5465
-
-
Garbutt, M.1
Liebscher, R.2
Wahl-Jensen, V.3
Jones, S.4
Moller, P.5
Wagner, R.6
-
4
-
-
22544441308
-
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
-
Jones SM, Feldmann H, Stroher U, Geisbert JB, Fernando L, Grolla A, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med. 2005;11:786-90. http://dx.doi.org/10.1038/nm1258
-
(2005)
Nat Med
, vol.11
, pp. 786-790
-
-
Jones, S.M.1
Feldmann, H.2
Stroher, U.3
Geisbert, J.B.4
Fernando, L.5
Grolla, A.6
-
5
-
-
80054741833
-
Recombinant vesicular stomatitis virus- based vaccines against Ebola and Marburg virus infections
-
Geisbert TW, Feldmann H. Recombinant vesicular stomatitis virus- based vaccines against Ebola and Marburg virus infections. J Infect Dis. 2011;204(Suppl 3):S1075-81. http://dx.doi. org/10.1093/infdis/jir349
-
(2011)
J Infect Dis
, vol.204
, pp. S1075-S1081
-
-
Geisbert, T.W.1
Feldmann, H.2
-
6
-
-
57149112519
-
Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates
-
Geisbert TW, Daddario-Dicaprio KM, Lewis MG, Geisbert JB, Grolla A, Leung A, et al. Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog. 2008;4:e1000225. http://dx.doi. org/10.1371/journal.ppat.1000225
-
(2008)
Plos Pathog
, pp. 4
-
-
Geisbert, T.W.1
Daddario-Dicaprio, K.M.2
Lewis, M.G.3
Geisbert, J.B.4
Grolla, A.5
Leung, A.6
-
7
-
-
84859181562
-
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman promates. PLoS Negl Trop Dis. 2012;6:E1567
-
Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG, et al. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman promates. PLoS Negl Trop Dis. 2012;6:e1567. Epub 2012 Mar 20.
-
(2012)
Epub
, pp. 20
-
-
Mire, C.E.1
Miller, A.D.2
Carville, A.3
Westmoreland, S.V.4
Geisbert, J.B.5
Mansfield, K.G.6
-
8
-
-
84924958113
-
OIE-listed diseases
-
[cited 2015 Jan 20]
-
World Organisation for Animal Health (OIE). OIE-listed diseases, infections and infestations in force in 2014 [cited 2015 Jan 20]. http://www.oie.int/en/animal-health-in-the-world/oie-listeddiseases- 2014/
-
(2015)
Infections and Infestations in Force in 2014
-
-
-
9
-
-
4544333574
-
Effect of strain and serotype of vesicular stomatitis virus on viral shedding, vesicular lesion development, and contact transmission in pigs
-
Stallknecht DE, Greer JB, Murphy MD, Mead DG, Howerth EW. Effect of strain and serotype of vesicular stomatitis virus on viral shedding, vesicular lesion development, and contact transmission in pigs. Am J Vet Res. 2004;65:1233-9. http://dx.doi.org/10.2460/ajvr.2004.65.1233
-
(2004)
Am J Vet Res
, vol.65
, pp. 1233-1239
-
-
Stallknecht, D.E.1
Greer, J.B.2
Murphy, M.D.3
Mead, D.G.4
Howerth, E.W.5
-
10
-
-
80054753979
-
Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy
-
Marzi A, Ebihara H, Callison J, Groseth A, Williams KJ, Geisbert TW, et al. Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis. 2011;204(Suppl 3):S1066-74. http://dx.doi.org/10.1093/infdis/jir348
-
(2011)
J Infect Dis
, vol.204
, pp. S1066-S1074
-
-
Marzi, A.1
Ebihara, H.2
Callison, J.3
Groseth, A.4
Williams, K.J.5
Geisbert, T.W.6
-
11
-
-
78449264916
-
Enzyme-linked immunosorbent assay for the detection of filovirus species-specific antibodies
-
Nakayama E, Yokoyama A, Miyamoto H, Igarashi M, Kishida N, Matsuno K, et al. Enzyme-linked immunosorbent assay for the detection of filovirus species-specific antibodies. Clin Vaccine Immunol. 2010;17:1723-8. http://dx.doi.org/10.1128/CVI.00170-10
-
(2010)
Clin Vaccine Immunol
, vol.17
, pp. 1723-1728
-
-
Nakayama, E.1
Yokoyama, A.2
Miyamoto, H.3
Igarashi, M.4
Kishida, N.5
Matsuno, K.6
|